Introduction Trontinemab has emerged as a significant player in the field of autoimmune therapies, gaining attention from medical professionals and researchers alike. Its relevance is underscored by the increasing prevalence of autoimmune diseases globally, which affect millions of individuals and often lead to chronic health issues. By targeting specific pathways involved in the immune response,